Evidence map›Paper›PMID 41507951›Full record

ReviewJournal of translational medicine2026

Clinical research in private hospitals: a perspective.

Laetitia Rossier, Tiia Snäkä, Michele Graciotti, Miriam Hernandez, Oscar Matzinger, Jacques Bernier, Lana Kandalaft

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laetitia Rossier *Swiss Medical Network, Clinique de Genolier, Genolier, Switzerland.
Tiia Snäkä *Swiss Medical Network, Clinique de Genolier, Genolier, Switzerland.
Michele GraciottiSwiss Medical Network, Clinique de Genolier, Genolier, Switzerland.
Miriam HernandezSwiss Medical Network, Clinique de Genolier, Genolier, Switzerland.
Oscar MatzingerSwiss Medical Network, Clinique de Genolier, Genolier, Switzerland.
Jacques BernierSwiss Medical Network, Clinique de Genolier, Genolier, Switzerland.
Lana KandalaftSwiss Medical Network, Clinique de Genolier, Genolier, Switzerland. lana.kandalaft@unil.ch.ORCID 0000-0002-1575-6674

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe expansion of clinical research beyond academic hospitals into private hospitals is reshaping the way new therapies are tested and implemented. Traditionally, university and public hospitals have been the primary drivers of clinical research, yet private hospitals are increasingly positioned to contribute meaningfully to this landscape. DISCUSSION: This perspective explores the opportunities and complexities of establishing a clinical trial unit within a private setting, highlighting strategies to conduct innovative studies and deliver high-quality, patient-centered research. While private hospitals may face initial challenges related to infrastructure, regulatory compliance, and quality assurance, they offer important advantages, including more rapid decision-making, streamlined administrative pathways, and efficiency in initiating and conducting studies, all while adhering to the same regulatory requirements.

conclusionBy positioning themselves as complementary partners to academic institutions, private hospitals can provide efficient and fast paced environments for industry-sponsored trials, ultimately enriching the broader research ecosystem. Most importantly, these developments enable the realization of personalized medicine, where cutting-edge, individualized therapies, particularly in oncology, can be directly tailored and delivered to patients, transforming the promise of precision medicine into real clinical outcomes.

Indexed as

Biomedical ResearchHospitals, PrivateClinical Trials as TopicHumansCancer vaccinesClinical researchClinical trial unitPrivate health sectorPrivate hospitals

Identifiers

PMID41507951
PMCPMC12882213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.